DYADIC INTERNATIONAL INC Accrued Liabilities, Current
DYADIC INTERNATIONAL INC (DYAI) had Accrued Liabilities, Current of $1.40 million as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current › Accrued Liabilities, Current
us-gaap:AccruedLiabilitiesCurrent · last filed 2026-08-12
- 2026-06-30: Accrued Liabilities, Current $1.40M.
- 2026-03-31: Accrued Liabilities, Current $891.42K.
- 2025-12-31: Accrued Liabilities, Current $967.97K.
- 2025-09-30: Accrued Liabilities, Current $1.37M.
| Period end | Accrued Liabilities, Current |
|---|---|
| 2026-06-30 | $1.40M 10-Q · filed 2026-08-12 |
| 2026-03-31 | $891.42K 10-Q · filed 2026-05-13 |
| 2025-12-31 | $967.97K 10-Q · filed 2026-08-12 |
| 2025-09-30 | $1.37M 10-Q · filed 2025-11-12 |
| 2025-06-30 | $929.85K 10-Q · filed 2025-08-13 |
| 2025-03-31 | $690.86K 10-Q · filed 2025-05-14 |
| 2024-12-31 | $970.46K 10-K · filed 2026-03-25 |
| 2024-09-30 | $839.42K 10-Q · filed 2024-11-12 |
| 2024-06-30 | $870.60K 10-Q · filed 2024-08-13 |
| 2024-03-31 | $987.97K 10-Q · filed 2024-05-14 |
| 2023-12-31 | $1.06M 10-K · filed 2025-03-26 |
| 2023-09-30 | $620.24K 10-Q · filed 2023-11-08 |
| 2023-06-30 | $909.48K 10-Q · filed 2023-08-09 |
| 2023-03-31 | $863.04K 10-Q · filed 2023-05-10 |
| 2022-12-31 | $955.08K 10-K · filed 2024-03-28 |
| 2022-09-30 | $987.89K 10-Q · filed 2022-11-10 |
| 2022-06-30 | $1.22M 10-Q · filed 2022-08-10 |
| 2022-03-31 | $533.01M 10-Q · filed 2022-05-12 |
| 2022-01-01 | $533.01M 10-Q · filed 2022-05-12 |
| 2021-12-31 | $709.56K 10-K · filed 2023-03-29 |
| 2021-09-30 | $842.45K 10-Q · filed 2021-11-10 |
| 2021-06-30 | $594.80K 10-Q · filed 2021-08-12 |
| 2021-03-31 | $277.67K 10-Q · filed 2021-05-13 |
| 2020-12-31 | $489.76K 10-K · filed 2022-03-29 |
| 2020-09-30 | $620.63K 10-Q · filed 2020-11-12 |
| 2020-06-30 | $378.12K 10-Q · filed 2020-08-13 |
| 2020-03-31 | $240.00K 10-Q · filed 2020-05-14 |
| 2019-12-31 | $566.00K 10-K · filed 2021-03-30 |
| 2019-09-30 | $470.12K 10-Q · filed 2019-11-13 |
| 2019-06-30 | $396.04K 10-Q · filed 2019-08-13 |
| 2019-03-31 | $302.97K 10-Q · filed 2019-05-09 |
| 2018-12-31 | $399.58K 10-K · filed 2020-03-30 |
| 2017-12-31 | $147.96K 10-K · filed 2019-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| Pluri Inc. (PLUR) | $0.014B | ||
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |